• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Iranian Journal of Pharmaceutical Research
Articles in Press
Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue supplement
Issue Issue 1
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Mahmoodi, N., Motamed, N., Paylakhi, S., Nosrat o. Mahmoodi, N. (2015). Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation. Iranian Journal of Pharmaceutical Research, 14(2), 521-530.
Narges Mahmoodi; Nasrin Motamed; Seyed Hasan Paylakhi; Nosrat o. Nosrat o. Mahmoodi. "Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation". Iranian Journal of Pharmaceutical Research, 14, 2, 2015, 521-530.
Mahmoodi, N., Motamed, N., Paylakhi, S., Nosrat o. Mahmoodi, N. (2015). 'Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation', Iranian Journal of Pharmaceutical Research, 14(2), pp. 521-530.
Mahmoodi, N., Motamed, N., Paylakhi, S., Nosrat o. Mahmoodi, N. Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation. Iranian Journal of Pharmaceutical Research, 2015; 14(2): 521-530.

Comparing the Effect of Silybin and Silybin Advanced™ on Viability and HER2 Expression on the Human Breast Cancer SKBR3 Cell Line by no Serum Starvation

Article 20, Volume 14, Issue 2, Spring 2015, Page 521-530  XML PDF (672 K)
Document Type: Research article
Authors
Narges Mahmoodi 1; Nasrin Motamed1; Seyed Hasan Paylakhi2; Nosrat o. Nosrat o. Mahmoodi3
1University of Tehran
2School of Biology, Damghan University, Damghan, Iran
3Department of Chemistry, Faculty of Science, University of Guilan
Abstract
The polyphenol silybin has anti-oxidant and anti-cancer properties. The poor bioavailability of some polyphenols (flavonoids, and terpenoids) can be improved by binding them to phosphatidylcholine (phytosome technology). Many studies have focused on the most common phytosome, silybin-phosphatidylcholine, particularly for its hepatoprotective effects. However, in recent years, studies have also been conducted to determine its anti-cancer effect. Considering that the serum starvation should not be used for studies that are not focused on cell cycle arrest, we studied the effect of silybin-phosphatidylcholine from Silybin Advanced™ in 1:2 ratio (one part silybin bound to two parts phosphatidylcholine) on HER2 gene expression on the SKBR3 breast cancer cell line which were cultured in complete medium (not serum deprivation). The results were compared with our previous study of silybin on HER2 expression on SKBR3 cells.
An MTT test was used to determine concentrations for cell treatment, and the gene expression was defined by real-time RT-PCR.
Outcomes showed significant concentration- and time-dependent cell growth inhibitory effects of silybin, and silybin-phosphatidylcholine and HER2 down regulation on SKBR3 cells. Silybin-phosphatidylcholine concentrations had a much larger inhibitory and HER2 down regulate effect on cell growth than the same silybin concentrations on SKBR3 cells.
Keywords
Breast Cancer; HER2; Silybin Advanced™; real-time RT-PCR
Main Subjects
toxicology and Pharmacology
Statistics
Article View: 4,760
PDF Download: 11,747
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.